مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats.
Normal view MARC view ISBD view

Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats. [electronic resource]

By:
  • Nagai, Nobuhiro
Contributor(s):
  • Nezhad, Zhaleh Kashkouli
  • Daigaku, Reiko
  • Saijo, Saaya
  • Song, Yuanhui
  • Terata, Keiko
  • Hoshi, Ayako
  • Nishizawa, Matsuhiko
  • Nakazawa, Toru
  • Kaji, Hirokazu
  • Abe, Toshiaki
Producer: 20191230Description: 118458 p. digitalISSN:
  • 1873-3476
Subject(s):
  • Angiogenesis Inhibitors -- administration & dosage
  • Animals
  • Chitosan -- administration & dosage
  • Choroidal Neovascularization -- drug therapy
  • Collagen -- administration & dosage
  • Drug Implants -- administration & dosage
  • Drug Liberation
  • Eye -- drug effects
  • Fluorescein-5-isothiocyanate -- administration & dosage
  • Gelatin -- administration & dosage
  • Lasers
  • Male
  • Methacrylates -- administration & dosage
  • Polyethylene Glycols -- administration & dosage
  • Ranibizumab -- administration & dosage
  • Rats, Sprague-Dawley
  • Serum Albumin -- administration & dosage
Online resources:
  • Available from publisher's website
In: International journal of pharmaceutics vol. 567
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats.

APA

Nagai N., Nezhad Z. K., Daigaku R., Saijo S., Song Y., Terata K., Hoshi A., Nishizawa M., Nakazawa T., Kaji H. & Abe T. (20191230). Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats. : International journal of pharmaceutics.

Chicago

Nagai Nobuhiro, Nezhad Zhaleh Kashkouli, Daigaku Reiko, Saijo Saaya, Song Yuanhui, Terata Keiko, Hoshi Ayako, Nishizawa Matsuhiko, Nakazawa Toru, Kaji Hirokazu and Abe Toshiaki. 20191230. Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats. : International journal of pharmaceutics.

Harvard

Nagai N., Nezhad Z. K., Daigaku R., Saijo S., Song Y., Terata K., Hoshi A., Nishizawa M., Nakazawa T., Kaji H. and Abe T. (20191230). Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats. : International journal of pharmaceutics.

MLA

Nagai Nobuhiro, Nezhad Zhaleh Kashkouli, Daigaku Reiko, Saijo Saaya, Song Yuanhui, Terata Keiko, Hoshi Ayako, Nishizawa Matsuhiko, Nakazawa Toru, Kaji Hirokazu and Abe Toshiaki. Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats. : International journal of pharmaceutics. 20191230.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site